Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Smoot

Showing results (151-160 of 180) with videos related to

Pageof 18
Sort By:
Surgery|January 30, 2020
Impact of resection margin status on survival in pancreatic cancer patients after neoadjuvant treatment and pancreatoduodenectomyShimpei Maeda, Alexandra M Moore, Lavanya Yohanathan, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|July 2, 2022
Patency rates of hepatic arterial resection and revascularization in locally advanced pancreatic cancerRoberto Alva-Ruiz, Amro M Abdelrahman, Patrick P Starlinger, et al.
American Journal of Clinical Pathology|September 4, 2020
Molecular and Immunohistochemical Analysis of Mucinous Cystic Neoplasm of the LiverBenjamin J Van Treeck, Mira Lotfalla, Thomas W Czeczok, et al.
JHEP Reports : Innovation in Hepatology|April 8, 2026
Cell-SELEX identifies a DNA aptamer for highly selective in vivo siRNA delivery in cholangiocarcinomaBrandon A Wilbanks, Ayano Kabashima, Enis H Ozmert, et al.
British Journal of Clinical Pharmacology|February 2, 2022
Can nebulised HepArin Reduce morTality and time to Extubation in patients with COVID-19 Requiring invasive ventilation Meta-Trial (CHARTER-MT): Protocol and statistical analysis plan for an investigator-initiated international meta-trial of prospective randomised clinical studiesFrank M P van Haren, John G Laffey, Antonio Artigas, et al.
Annals of Surgical Oncology|November 1, 2021
Neoadjuvant Chemotherapy Switch in Borderline Resectable/Locally Advanced Pancreatic CancerRoberto Alva-Ruiz, Lavanya Yohanathan, Jennifer A Yonkus, et al.
Journal of Neuroendocrinology|June 30, 2026
Outcomes of liver resections for neuroendocrine tumor liver metastases in carcinoid heart diseaseMarkus Ammann, Hallbera Gudmundsdottir, Vanja Podrascanin, et al.
JHEP Reports : Innovation in Hepatology|March 18, 2020
Biliary tract cancer patient-derived xenografts: Surgeon impact on individualized medicineJennifer L Leiting, Stephen J Murphy, John R Bergquist, et al.
Hepatology (Baltimore, Md.)|February 10, 2025
Aptamer-directed, nanovesicle-mediated targeting of undruggable molecules in preclinical cholangiocarcinoma modelsMincheng Yu, Jack W Sample, Irene K Yan, et al.
Annals of Surgical Oncology|May 4, 2026
Neoadjuvant Therapy as a Selection Strategy for Curative Resection in High-Risk Intrahepatic CholangiocarcinomaYawen Dong, Kever A Lewis, David Pereyra, et al.
Pageof 18

Showing results (151-160 of 180) with videos related to

Sort By:
Pageof 18
Surgery|January 30, 2020
Impact of resection margin status on survival in pancreatic cancer patients after neoadjuvant treatment and pancreatoduodenectomyShimpei Maeda, Alexandra M Moore, Lavanya Yohanathan, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|July 2, 2022
Patency rates of hepatic arterial resection and revascularization in locally advanced pancreatic cancerRoberto Alva-Ruiz, Amro M Abdelrahman, Patrick P Starlinger, et al.
American Journal of Clinical Pathology|September 4, 2020
Molecular and Immunohistochemical Analysis of Mucinous Cystic Neoplasm of the LiverBenjamin J Van Treeck, Mira Lotfalla, Thomas W Czeczok, et al.
JHEP Reports : Innovation in Hepatology|April 8, 2026
Cell-SELEX identifies a DNA aptamer for highly selective in vivo siRNA delivery in cholangiocarcinomaBrandon A Wilbanks, Ayano Kabashima, Enis H Ozmert, et al.
British Journal of Clinical Pharmacology|February 2, 2022
Can nebulised HepArin Reduce morTality and time to Extubation in patients with COVID-19 Requiring invasive ventilation Meta-Trial (CHARTER-MT): Protocol and statistical analysis plan for an investigator-initiated international meta-trial of prospective randomised clinical studiesFrank M P van Haren, John G Laffey, Antonio Artigas, et al.
Annals of Surgical Oncology|November 1, 2021
Neoadjuvant Chemotherapy Switch in Borderline Resectable/Locally Advanced Pancreatic CancerRoberto Alva-Ruiz, Lavanya Yohanathan, Jennifer A Yonkus, et al.
Journal of Neuroendocrinology|June 30, 2026
Outcomes of liver resections for neuroendocrine tumor liver metastases in carcinoid heart diseaseMarkus Ammann, Hallbera Gudmundsdottir, Vanja Podrascanin, et al.
JHEP Reports : Innovation in Hepatology|March 18, 2020
Biliary tract cancer patient-derived xenografts: Surgeon impact on individualized medicineJennifer L Leiting, Stephen J Murphy, John R Bergquist, et al.
Hepatology (Baltimore, Md.)|February 10, 2025
Aptamer-directed, nanovesicle-mediated targeting of undruggable molecules in preclinical cholangiocarcinoma modelsMincheng Yu, Jack W Sample, Irene K Yan, et al.
Annals of Surgical Oncology|May 4, 2026
Neoadjuvant Therapy as a Selection Strategy for Curative Resection in High-Risk Intrahepatic CholangiocarcinomaYawen Dong, Kever A Lewis, David Pereyra, et al.
Pageof 18